US M&A deals of the week: 22 August 2025

US M&A deals of the week: 22 August 2025

Broadcasting, biotech, and wealth management dominated U.S. M&A this week. Nexstar’s $6.2 billion bid for Tegna led the headlines, while Honeywell added utility platforms, XOMA Royalty expanded in oncology, and wealth managers pursued consolidation. Mubadala’s take-private of CI Financial added sovereign weight to a diverse week of deals.








This week’s U.S. M&A activity reflects three converging forces: consolidation under industry pressure, regulatory recalibration, and the expanding influence of patient sovereign capital.

In media, Nexstar’s $6.2 billion bid for Tegna underscores the urgency for broadcasters to build scale as traditional advertising revenue erodes. Yet as Brian Wieser of Madison & Wall notes, “consolidation won’t be a quick fix” for TV ad weakness, with structural decline tied to digital platforms such as Amazon and The Trade Desk. Local journalism experts have also warned that consolidation may lead to thinner newsrooms and greater content duplication, risking further deterioration in community coverage.

In asset and wealth management, Mubadala Capital’s take-private of CI Financial highlights the growing role of sovereign wealth funds in anchoring long-term, cross-border deals. The transaction demonstrates how patient capital, unconstrained by quarterly earnings cycles, is reshaping ownership structures and favouring strategic continuity over shorter-term private equity plays.

In the industrial sector, Honeywell’s acquisition of SparkMeter’s utility platforms shows how corporates are pursuing digital capabilities via targeted deals rather than wholesale integrations. With decarbonisation and grid modernisation high on the policy agenda, embedded intelligence and analytics now carry greater value than physical infrastructure alone.

Finally, XOMA’s acquisition of Mural Oncology illustrates the shift in biotech from innovation funding to monetisation plays. With sector financing tightening, investors are increasingly willing to capture value by consolidating distressed assets and royalty streams, rather than banking on breakthrough pipelines.

  • Scale does not equal resilience in media: Nexstar–Tegna may deliver operational synergies, but without digital ad innovation, structural headwinds remain.
  • Digital capabilities drive industrial M&A: Honeywell’s focus on analytics and data integration reflects a wider shift in deal value.
  • Sovereign capital sets the pace in finance: Mubadala’s move signals growing appetite for stable, long-horizon assets in wealth management.

Stay ahead of the curve with Business Quarter’s weekly M&A briefing, a concise, authoritative roundup of the biggest deals, strategic plays, and market-moving partnerships.

Sign up now to get each week’s summary straight to your inbox.

← Back

Thank you for your response. ✨



  • US M&A deals of the month: April 2026

    US M&A deals of the month: April 2026

    April’s biggest US deals rewarded scale, infrastructure, and specialist capability. From building-products distribution to satellite networks and biopharma pipelines, acquirers backed assets that could extend moats quickly and hold up in volatile markets.


  • Opus Technology wins B Corp certification

    Opus Technology wins B Corp certification

    Opus Technology secures B Corp status after a three-year process. The certification adds formal external validation to its ESG programme across operations, people policies, and environmental management.


  • UK M&A deals of April 2026

    UK M&A deals of April 2026

    April’s UK dealmakers pursued scale, scarcity, and discounted valuations hard. Shell’s $16.4bn ARC deal led the month, while Intertek, Standard Life, Senior, and Advanced Medical Solutions showed buyers backing reserves, retirement assets, defence exposure, specialist healthcare, and undervalued UK-listed businesses.